摘要
(2R,4R)-4-甲基哌啶-2-甲酸通过酯化后,与(S)-2-[(叔丁氧羰基)氨基]-5-(3-硝基胍基)戊酸缩合,去Boc保护基,与3-甲基-8-喹啉磺酰氯缩合,再经酯水解、Pd/C氢化还原喹啉环及脱硝基保护、精制得抗血栓药物阿加曲班,总收率约12%,纯度99.5%。该合成方法操作简单,工艺稳定,适合工业化生产。
Argatroban, an antithrombotic drug, was synthesized from (2R,4R)-4-methylpiperidine-2-carboxylic acid via esterification, condensation with (S) -2- E (tert-butoxycarbonyl) amino] -5- (3-nitroguanidino) pentanoic acid, deprotection of Boc group, condensation with 3-methylquinoline-8-sulfonyl chloride, hydrolysis, Pd/C-catalyzed hydrogenation and simultaneous deprotection, and purification with an overall yield about 12% and a purity of 99.5%. This method was suitable for industrialization because of its simple operation and stable process.
出处
《中国医药工业杂志》
CAS
CSCD
北大核心
2015年第11期1161-1164,共4页
Chinese Journal of Pharmaceuticals
基金
河北省重点基础研究项目(12966417D)
关键词
阿加曲班
抗血栓药
催化加氢
合成
argatroban
antithrombotic agent
catalytic hydrogenation
synthesis